Dr Victor J. Moreno, PhD - University of Murcia

Dr Victor J. Moreno

PhD

University of Murcia

Murcia, Murcia | Spain

Main Specialties: Sports Medicine

Dr Victor J. Moreno, PhD - University of Murcia

Dr Victor J. Moreno

PhD

Introduction

Primary Affiliation: University of Murcia - Murcia, Murcia , Spain

Specialties:

Publications

100Publications

5049Reads

1Profile Views

1175PubMed Central Citations

False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.

Eur J Cancer Prev 2017 09;26(5):365-367

aCancer Prevention and Control Programme, Catalan Institute of Oncology, IDIBELL bDepartment of Gastroenterology and Hepatology, University Hospital of Bellvitge-IDIBELL cConsortium for Biomedical Research in Epidemiology and Public Health (CIBEResp) dDepartment of Gastroenterology and Hepatology, Hospital of Viladecans eDepartment of Clinical Sciences, University of Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0000000000000281DOI Listing
September 2017
18 Reads
3.031 Impact Factor

[Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].

Gac Sanit 2015 Nov-Dec;29(6):464-71. Epub 2015 Sep 2.

Prevención y Control del Cáncer, Instituto Catalán de Oncología-IDIBELL, L'Hospitalet de Llobregat, Barcelona, España; CIBER de Epidemiología y Salud Pública (CIBERESP), España; Departamento de Ciencias Clínicas, Universidad de Barcelona, L'Hospitalet de Llobregat, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gaceta.2015.07.002DOI Listing
May 2017
16 Reads
1.250 Impact Factor

Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.

Eur J Nutr 2017 Apr 2;56(3):1123-1133. Epub 2016 Feb 2.

Unit of Infections and Cancer (UNIC), Cancer Epidemiology Research Programme, IDIBELL, Institut Català d'Oncologia, Av. Gran Via 199 - 203, 2º, 08907, L'Hospitalet De Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00394-016-1162-8DOI Listing
April 2017
106 Reads
1 Citation
3.470 Impact Factor

Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.

Gac Sanit 2015 Jul-Aug;29(4):308-15. Epub 2015 Jan 19.

Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; School of Public Health, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gaceta.2014.12.003DOI Listing
March 2017
135 Reads
19 Citations
1.250 Impact Factor

Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis.

Clin Gastroenterol Hepatol 2017 03 5;15(3):461-462. Epub 2016 Oct 5.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2016.09.153DOI Listing
March 2017
9 Reads
7.900 Impact Factor

Transcriptional Regulator CNOT3 Defines an Aggressive Colorectal Cancer Subtype.

Cancer Res 2017 02 29;77(3):766-779. Epub 2016 Nov 29.

Department of Medical Oncology and Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-1346DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290184PMC
February 2017
18 Reads
2 Citations
9.330 Impact Factor

Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.

Dig Liver Dis 2016 Oct 21;48(10):1249-54. Epub 2016 Jun 21.

Cancer Prevention and Control Programme, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBEResp), Spain; Department of Clinical Sciences, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2016.06.011DOI Listing
October 2016
30 Reads
4 Citations
2.963 Impact Factor

Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.

Mol Cancer Res 2016 09 8;14(9):841-8. Epub 2016 Jun 8.

Institute of Predictive and Personalized Medicine of Cancer (IMPPC), Campus Can Ruti, Badalona, Spain. Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-Germans Trias i Pujol, Campus Can Ruti, Badalona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-16-0034DOI Listing
September 2016
6 Reads
7 Citations
4.380 Impact Factor

Night shift work and stomach cancer risk in the MCC-Spain study.

Occup Environ Med 2016 08 16;73(8):520-7. Epub 2016 Jun 16.

ISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/oemed-2016-103597DOI Listing
August 2016
106 Reads
3 Citations
3.270 Impact Factor

Algorithmic methods to infer the evolutionary trajectories in cancer progression.

Proc Natl Acad Sci U S A 2016 07 28;113(28):E4025-34. Epub 2016 Jun 28.

Courant Institute of Mathematical Sciences, New York University, New York, NY 10003.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1520213113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948322PMC
July 2016
3 Reads
7 Citations
9.810 Impact Factor

MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer.

Int J Mol Sci 2016 Jun 3;17(6). Epub 2016 Jun 3.

Medical Oncology Department, Oncohealth Institute, Health Research Institute FJD-UAM, University Hospital Fundación Jiménez Díaz, Avda. Reyes Católicos-2, 28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms17060878DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926412PMC
June 2016
35 Reads
4 Citations
2.862 Impact Factor

Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.

Mol Cancer Ther 2016 05 1;15(5):1106-12. Epub 2016 Apr 1.

Translational Research Laboratory, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. Department of Medical Oncology, Catalan Insitute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0820DOI Listing
May 2016
29 Reads
3 Citations
5.683 Impact Factor

Mutanome and expression of immune response genes in microsatellite stable colon cancer.

Oncotarget 2016 Apr;7(14):17711-25

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7293DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951244PMC
April 2016
17 Reads
1 Citation
6.360 Impact Factor

Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.

Sci Rep 2016 Feb 8;6:20697. Epub 2016 Feb 8.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, 08908 Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep20697DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745060PMC
February 2016
61 Reads
1 Citation
5.080 Impact Factor

Perinatal and childhood factors and risk of breast cancer subtypes in adulthood.

Cancer Epidemiol 2016 Feb 21;40:22-30. Epub 2015 Nov 21.

Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Avenida Monforte de Lemos 5, 28029 Madrid, Spain; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Pública, CIBERESP), Spain; Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro (IDIPHIM), Manuel de Falla 1, 28222 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canep.2015.11.004DOI Listing
February 2016
69 Reads
4 Citations
2.560 Impact Factor

Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).

Sci Rep 2016 Jan 20;6:19532. Epub 2016 Jan 20.

Cancer Prevention and Control Programme, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep19532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726304PMC
January 2016
16 Reads
1 Citation
5.080 Impact Factor

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.

Oncotarget 2015 Dec;6(42):44254-73

Biological Clues of The Invasive and Metastatic Phenotype Group, Molecular Oncology Department, Bellvitge Biomedical Research Institute (IDIBELL), 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.5471DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4792555PMC
December 2015
33 Reads
6 Citations
6.360 Impact Factor

AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.

Clin Cancer Res 2015 Nov;21(21):4985

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-1756DOI Listing
November 2015
6 Reads
2 Citations
8.722 Impact Factor

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors.

J Clin Oncol 2015 Oct 31;33(30):3401-8. Epub 2015 Aug 31.

Josep Tabernero, Rodrigo Dienstmann, Barbara Adamo, and Jordi Rodon, Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona; Emiliano Calvo, START Madrid, Centro Integral Oncológico Clara Campal; Victor Moreno, START Madrid, Hospital Fundación Jiménez Díaz, Madrid, Spain; Rastislav Bahleda, Anas Gazzah, and Jean-Charles Soria, Gustave Roussy Cancer Campus and University Paris-Sud, Villejuif; Antoine Italiano, Institut Bergonié, Bordeaux, France; Jeffrey R. Infante, Sarah Cannon Research Institute, Nashville, TN; Alain Mita, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA; Bob Zhong, Suso J. Platero, Moitreyee Chatterjee-Kishore, Vijay Peddareddigari, and Feng R. Luo, Janssen Research and Development, Raritan, NJ; and Johan W. Smit and Kim Stuyckens, Janssen Research and Development, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.60.7341DOI Listing
October 2015
84 Reads
52 Citations
18.430 Impact Factor

Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.

Clin Cancer Res 2015 Oct 12;21(20):4709-18. Epub 2015 Jun 12.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain. Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-0159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609254PMC
October 2015
28 Reads
11 Citations
8.722 Impact Factor

Corrigendum: genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Authors:
Fredrick R Schumacher Stephanie L Schmit Shuo Jiao Christopher K Edlund Hansong Wang Ben Zhang Li Hsu Shu-Chen Huang Christopher P Fischer John F Harju Gregory E Idos Flavio Lejbkowicz Frank J Manion Kevin McDonnell Caroline E McNeil Marilena Melas Hedy S Rennert Wei Shi Duncan C Thomas David J Van Den Berg Carolyn M Hutter Aaron K Aragaki Katja Butterbach Bette J Caan Christopher S Carlson Stephen J Chanock Keith R Curtis Charles S Fuchs Manish Gala Edward L Giovannucci Stephanie M Gogarten Richard B Hayes Brian Henderson David J Hunter Rebecca D Jackson Laurence N Kolonel Charles Kooperberg Sébastien Küry Andrea LaCroix Cathy C Laurie Cecelia A Laurie Mathieu Lemire David Levine Jing Ma Karen W Makar Conghui Qu Darin Taverna Cornelia M Ulrich Kana Wu Suminori Kono Dee W West Sonja I Berndt Stephane Bezieau Hermann Brenner Peter T Campbell Andrew T Chan Jenny Chang-Claude Gerhard A Coetzee David V Conti David Duggan Jane C Figueiredo Barbara K Fortini Steven J Gallinger W James Gauderman Graham Giles Roger Green Robert Haile Tabitha A Harrison Michael Hoffmeister John L Hopper Thomas J Hudson Eric Jacobs Motoki Iwasaki Sun Ha Jee Mark Jenkins Wei-Hua Jia Amit Joshi Li Li Noralene M Lindor Keitaro Matsuo Victor Moreno Bhramar Mukherjee Polly A Newcomb John D Potter Leon Raskin Gad Rennert Stephanie Rosse Gianluca Severi Robert E Schoen Daniela Seminara Xiao-Ou Shu Martha L Slattery Shoichiro Tsugane Emily White Yong-Bing Xiang Brent W Zanke Wei Zheng Loic Le Marchand Graham Casey Stephen B Gruber Ulrike Peters

Nat Commun 2015 Oct 26;6:8739. Epub 2015 Oct 26.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms9739DOI Listing
October 2015
151 Reads
3 Citations
10.742 Impact Factor

Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.

Menopause 2015 Oct;22(10):1138-46

1Unit of Infections and Cancer, Cancer Epidemiology Research Program, IDIBELL, Catalan Institute of Oncology, Barcelona, Spain 2Department of Medicine, University of Barcelona, Barcelona, Spain 3Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiologia y Salud Pública), Madrid, Spain 4Preventive Medicine and Epidemiology Service, Hospital Clínic of Barcelona, Barcelona, Spain 5Public Health Division of Gipuzkoa, San Sebastian, Spain 6Biodonostia Research Institute, San Sebastian, Spain 7Environmental and Cancer Epidemiology Area, National Center of Epidemiology, Carlos III Institute of Health, Madrid, Spain 8Cancer Epidemiology Research Group, Oncology and Hematology Area, IIS Puerta de Hierro, Madrid, Spain 9Grupo de Investigación en Interacciones Gen-Ambiente y Salud, Universidad de León, León, Spain 10Universidad de Cantabria-IDIVAL, Santander, Spain 11Public Health Institute of Navarra, Pamplona, Spain 12Red de Investigación en Servicios de Salud en Enfermedades Crónicas, Madrid, Spain 13Institute of Oncology, IUOPA, University of Oviedo, Oviedo, Spain 14Cancer Prevention Program, Catalan Institute of Oncology, IDIBELL, Barcelona, Spain 15Servicio de Medicina Interna, Complejo Hospitalario de Huelva-Hospital Infanta Elena, CYSMA, Huelva, Spain 16Fundación para el Fomento de la Investigación Sanitaria y Biomédica, FISABIO, Breast Cancer Screening Program, Valencian Public Health Directorate, Valencia, Spain 17Departamento de Medicina Preventiva y Salud Pública, Universidad de Granada, Granada, Spain 18Instituto de Investigación Biosanitaria de Granada, Complejo Hospitalario de Granada, Servicio Andaluz de Salud/Universidad de Granada, Granada, Spain 19Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia and Descriptive Epidemiology, Genetics and Cancer Prevention Group (Girona Biomedical Research Institute), Catalan Institute of Oncology, G

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/menopausejournal/2015/10000/Hor
Web Search
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/GME.0000000000000487DOI Listing
October 2015
102 Reads
3 Citations
3.361 Impact Factor

A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.

Anticancer Drugs 2015 Oct;26(9):1004-7

aMedical Oncology Department bPrecision Oncology Laboratory (POL) cPathology Department, Infanta Sofía University Hospital dIMDEA-Food Institute, CEI UAM+CSIC eClinical Research Phase 1 Trials Unit, START Madrid-FJD, Hospital Fundación Jiménez Díaz Fundación Jiménez Díaz, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000277DOI Listing
October 2015
22 Reads
4 Citations
1.891 Impact Factor

An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.

Dig Liver Dis 2015 Sep 15;47(9):797-804. Epub 2015 May 15.

Department of Gastroenterology and Hepatology, University Hospital of Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.dld.2015.05.004DOI Listing
September 2015
43 Reads
5 Citations
2.963 Impact Factor

Dietary flavonoids, lignans and colorectal cancer prognosis.

Sci Rep 2015 Sep 15;5:14148. Epub 2015 Sep 15.

Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep14148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572925PMC
September 2015
14 Reads
1 Citation
5.080 Impact Factor

Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.

Int J Mol Sci 2015 Aug 17;16(8):19447-57. Epub 2015 Aug 17.

Group of Cancer Biomarkers, Pathology Department, Health Research Institute Fundación Jiménez Díaz (IIS-FJD, UAM), Avda. Reyes Católicos.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms160819447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581306PMC
August 2015
65 Reads
2.862 Impact Factor

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Endocr Relat Cancer 2015 Aug 22;22(4):545-59. Epub 2015 Jun 22.

Genomic Oncology AreaGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, SpainHematology DepartmentVirgen de las Nieves University Hospital, Granada, SpainGenomic Epidemiology GroupGerman Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of BiologyUniversity of Pisa, Pisa, ItalyDepartment of HematologyHospital Universitario Doce de Octubre, Madrid, SpainArea of Genomic MedicineGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, SpainSemmelweis UniversityBudapest, HungaryHaematology DepartmentUniversity Hospital of Salamanca and IBSAL, Salamanca, SpainMedical University of LodzLodz, PolandINSERM UMR 1052/CNRS 5286Université Claude Bernard Lyon I, Lyon, FranceMorales Meseguer General University HospitalMurcia, SpainHaematoloy ClinikHolly Cross Cancer Center, Kielce, PolandINSERMU900, Genetic Epidemiology of Cancers team, Institut Curie, Mines ParisTech, Paris, FranceLife and Health Sciences Research Institute (ICVS)School of Health Sciences, University of Minho, Braga, PortugalICVS/3B's - PT Government Associate LaboratoryBraga/Guimarães, PortugalMolecular Oncology Research CenterBarretos Cancer Hospital, Barretos, BrazilIDIBELL - Catalan Institute of OncologyUniversity of Barcelona, Barcelona 08907, SpainDepartment of HematologyCracow University Hospital, Cracow, PolandOrgan CenterHospital of Southern Jutland, DK-6200 Aabenraa, DenmarkFaculty of Health SciencesInstitute of Regional Health Research, University of Southern Denmark, DK-5000 Odense C, DenmarkUO HematologyDepartment of Internal and Experimental Medicine, University of Pisa, Pisa, ItalyClinic of Biochemistry and ImmunologyLaboratory Center, Hospital of Southern Jutland, Aabenraa, DenmarkDepartment of HaematologyRigshospitalet and Roskilde Hospital, Copenhagen University, Copenhagen, Denmark Genomic Oncology AreaGENYO, Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0029DOI Listing
August 2015
47 Reads
1 Citation
4.805 Impact Factor

Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.

Clin Epigenetics 2015 24;7:74. Epub 2015 Jul 24.

Institute of Predictive and Personalized Medicine of Cancer (IMPPC, Ctra Can Ruti, Cami de les Escoles, Badalona, 08916 Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-015-0110-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512023PMC
July 2015
9 Reads
9 Citations

Genome-wide association study of colorectal cancer identifies six new susceptibility loci.

Authors:
Fredrick R Schumacher Stephanie L Schmit Shuo Jiao Christopher K Edlund Hansong Wang Ben Zhang Li Hsu Shu-Chen Huang Christopher P Fischer John F Harju Gregory E Idos Flavio Lejbkowicz Frank J Manion Kevin McDonnell Caroline E McNeil Marilena Melas Hedy S Rennert Wei Shi Duncan C Thomas David J Van Den Berg Carolyn M Hutter Aaron K Aragaki Katja Butterbach Bette J Caan Christopher S Carlson Stephen J Chanock Keith R Curtis Charles S Fuchs Manish Gala Edward L Giovannucci Stephanie M Gogarten Richard B Hayes Brian Henderson David J Hunter Rebecca D Jackson Laurence N Kolonel Charles Kooperberg Sébastien Küry Andrea LaCroix Cathy C Laurie Cecelia A Laurie Mathieu Lemire David Levine Jing Ma Karen W Makar Conghui Qu Darin Taverna Cornelia M Ulrich Kana Wu Suminori Kono Dee W West Sonja I Berndt Stéphane Bezieau Hermann Brenner Peter T Campbell Andrew T Chan Jenny Chang-Claude Gerhard A Coetzee David V Conti David Duggan Jane C Figueiredo Barbara K Fortini Steven J Gallinger W James Gauderman Graham Giles Roger Green Robert Haile Tabitha A Harrison Michael Hoffmeister John L Hopper Thomas J Hudson Eric Jacobs Motoki Iwasaki Sun Ha Jee Mark Jenkins Wei-Hua Jia Amit Joshi Li Li Noralene M Lindor Keitaro Matsuo Victor Moreno Bhramar Mukherjee Polly A Newcomb John D Potter Leon Raskin Gad Rennert Stephanie Rosse Gianluca Severi Robert E Schoen Daniela Seminara Xiao-Ou Shu Martha L Slattery Shoichiro Tsugane Emily White Yong-Bing Xiang Brent W Zanke Wei Zheng Loic Le Marchand Graham Casey Stephen B Gruber Ulrike Peters

Nat Commun 2015 Jul 7;6:7138. Epub 2015 Jul 7.

Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98124, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms8138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967357PMC
July 2015
140 Reads
31 Citations
10.742 Impact Factor

Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?

Eur J Cancer Prev 2015 Jul;24(4):321-7

aCancer Prevention and Control Program bPharmacy Department, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat Departments of cFundamental Care and Medical-Surgical Nursing dClinical Sciences, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CEJ.0000000000000090DOI Listing
July 2015
93 Reads
3.031 Impact Factor

MicroRNA-21 predicts response to preoperative chemoradiotherapy in locally advanced rectal cancer.

Int J Colorectal Dis 2015 Jul 8;30(7):899-906. Epub 2015 May 8.

Medical Oncology Department, University Hospital "Fundación Jimenez Diaz", Avda. Reyes Católicos-2, 28040, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00384-015-2231-9DOI Listing
July 2015
44 Reads
11 Citations
2.450 Impact Factor

Discovery and validation of new potential biomarkers for early detection of colon cancer.

PLoS One 2014 12;9(9):e106748. Epub 2014 Sep 12.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO) and CIBERESP, Hospitalet de Llobregat, Barcelona, Spain; Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona (UB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0106748PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162553PMC
May 2015
94 Reads
9 Citations
3.234 Impact Factor

Altered pathways and colorectal cancer prognosis.

BMC Med 2015 Apr 8;13:76. Epub 2015 Apr 8.

Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and Consortium for Biomedical Research in Epidemiology and Public Health (CIBEResp), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0307-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389340PMC
April 2015
4 Reads
1 Citation
7.250 Impact Factor

miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.

Nat Commun 2015 Apr 15;6:6879. Epub 2015 Apr 15.

1] School of Electrical and Computer Engineering, Cornell University, Ithaca, New York 14853, USA [2] Department of Biomedical Engineering, Cornell University, Ithaca, New York 14853, USA [3] Department of Biological and Environmental Engineering, Cornell University, Ithaca, New York 14853, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncomms7879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399006PMC
April 2015
32 Reads
28 Citations
10.742 Impact Factor

Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.

Oncologist 2015 Feb 5;20(2):127-33. Epub 2015 Jan 5.

Departments of Gastrointestinal Medical Oncology and Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona, Spain; Department of Surgery, Klinikum Rechts der Isar, Technische University, Munich, Germany; Institut Català d'Oncologia, IDIBELL L'Hospitalet de Llobregat, Barcelona, Spain; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain; Department of Surgery, Medical University of Vienna, Vienna, Austria; Department of Surgery, University of Ferrara, Ferrara, Italy; Agendia NV, Amsterdam, The Netherlands; Agendia Inc., Irvine, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2014-0325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319631PMC
February 2015
15 Reads
15 Citations
4.870 Impact Factor

Intrinsic cancer subtypes--next steps into personalized medicine.

Cell Oncol (Dordr) 2015 Feb 14;38(1):3-16. Epub 2015 Jan 14.

Department of Medical Oncology, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Av. Gran Via 199-203, 08907, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-014-0203-7DOI Listing
February 2015
45 Reads
10 Citations
3.032 Impact Factor

Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer.

PLoS One 2013 25;8(11):e80158. Epub 2013 Nov 25.

Cancer Prevention and Control Program, Catalan Institute of Oncology, Barcelona, Spain ; Colorectal Cancer Group, Bellvitge Biomedical Research Institute and Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0080158PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839967PMC
January 2015
18 Reads
8 Citations
3.234 Impact Factor

Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study.

Genes Nutr 2015 Jan 9;10(1):447. Epub 2014 Dec 9.

Biomarkers Group, Nutrition and Metabolism Section, International Agency for Research on Cancer (IARC), Lyon, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12263-014-0447-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259879PMC
January 2015
23 Reads
41 Citations
2.794 Impact Factor

Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.

PLoS One 2014 3;9(2):e86063. Epub 2014 Feb 3.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0086063PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3911901PMC
December 2014
25 Reads
8 Citations
3.234 Impact Factor

Use of urinary trichloroacetic acid as an exposure biomarker of disinfection by-products in cancer studies.

Environ Res 2014 Nov 14;135:276-84. Epub 2014 Oct 14.

Centre for Research in Environmental Epidemiology (CREAL), Doctor Aiguader 88, 08003 Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain; IMIM (Hospital del Mar Medical Research Institute), Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2014.09.018DOI Listing
November 2014
3 Reads
1 Citation
4.373 Impact Factor

Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information.

Mol Oncol 2014 Oct 6;8(7):1290-305. Epub 2014 May 6.

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, 08908 Catalonia, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.04.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528579PMC
October 2014
27 Reads
21 Citations
5.331 Impact Factor

Large differences in global transcriptional regulatory programs of normal and tumor colon cells.

BMC Cancer 2014 Sep 24;14:708. Epub 2014 Sep 24.

Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Av Gran Via 199-203, E-08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-708DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182786PMC
September 2014
15 Reads
7 Citations
3.362 Impact Factor

Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.

Carcinogenesis 2014 Sep 23;35(9):2039-46. Epub 2014 Apr 23.

Cancer Prevention and Control Program, Catalan Institute of Oncology, and Consortium for Biomedical Research on Epidemiology and Public Health (CIBERESP), Barcelona E08907, Spain, Colorectal Cancer Group, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona E08907, Spain, Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona E08907, Spain,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgu092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146415PMC
September 2014
11 Reads
14 Citations
5.334 Impact Factor

Statistical inference for Hardy-Weinberg proportions in the presence of missing genotype information.

PLoS One 2013 31;8(12):e83316. Epub 2013 Dec 31.

Cancer Prevention and Control Program, Catalan Institute of Oncology (ICO), Biomedical Research Institute of Bellvitge (IDIBELL), Consorcio de Investigación Biomédica de Epidemiología y Salud Pública (CIBERESP), and School of Medicine, University of Barcelona (UB), Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083316PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877411PMC
August 2014
14 Reads
4 Citations
3.234 Impact Factor

Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.

Eur J Cancer 2014 Jul 16;50(11):1964-72. Epub 2014 May 16.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.04.022DOI Listing
July 2014
19 Reads
3 Citations
5.420 Impact Factor

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1115DOI Listing
April 2014
110 Reads
3 Citations
4.125 Impact Factor

Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.

Mol Cancer 2014 Mar 5;13:46. Epub 2014 Mar 5.

Unit of Biomarkers and Susceptibility, Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1476-4598-13-46DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023701PMC
March 2014
25 Reads
23 Citations
4.260 Impact Factor

Raman identification of drug of abuse particles collected with colored and transparent tapes.

Sci Justice 2014 Mar 9;54(2):164-9. Epub 2014 Jan 9.

Department of Analytical Chemistry, Physical Chemistry, and Chemical Engineering, Multipurpose Building of Chemistry, University of Alcalá, Ctra. Madrid-Barcelona, Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain; University Institute of Research in Police Sciences, Multipurpose Building of Chemistry, University of Alcalá, Ctra. Madrid-Barcelona, Km. 33.600, 28871 Alcalá de Henares, Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scijus.2013.12.003DOI Listing
March 2014
9 Reads
1.420 Impact Factor

Phase 1 study of cetuximab in combination with 5-fluorouracil, cisplatin, and radiotherapy in patients with locally advanced anal canal carcinoma.

Cancer 2014 Feb 14;120(3):454-6. Epub 2013 Nov 14.

Medical Oncology Service, La Paz University Hospital, Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28449DOI Listing
February 2014
11 Reads
1 Citation
4.890 Impact Factor

[Benign tumors of vulva: review and case report of achrocordon].

Medwave 2014 Jan 17;14(1):e5886. Epub 2014 Jan 17.

Hospital General Amecameca, Estado de México- ISEM, México.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5867/medwave.2014.01.5886DOI Listing
January 2014
12 Reads

Molecular markers to predict outcome to antiangiogenic therapies in colorectal cancer: current evidence and future perspectives.

Cancer Treat Rev 2013 Dec 16;39(8):908-24. Epub 2013 Mar 16.

Medical Oncology Department, IDiPAZ, RTICC (RD06/0020/1022), La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2013.02.004DOI Listing
December 2013
19 Reads
9 Citations
7.590 Impact Factor

Telomere length and genetic anticipation in Lynch syndrome.

PLoS One 2013 23;8(4):e61286. Epub 2013 Apr 23.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061286PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3634050PMC
November 2013
74 Reads
8 Citations
3.234 Impact Factor

Thymoma and thymic carcinoma in the target therapies era.

Cancer Treat Rev 2013 Aug 20;39(5):413-20. Epub 2012 Dec 20.

Hospital Universitario La Paz, Pso Castellana 261, 28046 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.11.005DOI Listing
August 2013
34 Reads
8 Citations
7.590 Impact Factor

The mid p-value in exact tests for Hardy-Weinberg equilibrium.

Stat Appl Genet Mol Biol 2013 Aug;12(4):433-48

Department of Statistics and Operations Research, Universitat Politècnica de Catalunya, Avinguda Diagonal 647, Barcelona, Spain

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/sagmb-2012-0039DOI Listing
August 2013
131 Reads
15 Citations

DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.

Cancer Prev Res (Phila) 2013 Jul 21;6(7):656-65. Epub 2013 May 21.

Cancer Epigenetics and Biology Program (PEBC), Catalan Institute of Oncology (ICO-IDIBELL), Barcelona 08908, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-12-0501DOI Listing
July 2013
31 Reads
33 Citations

Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.

PLoS One 2012 7;7(11):e48877. Epub 2012 Nov 7.

Unit of Biomarkers and Susceptibility (UBS), Catalan Institute of Oncology (ICO), Bellvitge Biomedical Research Institute (IDIBELL), and CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048877PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492249PMC
May 2013
9 Reads
31 Citations
3.234 Impact Factor

Assessment of Argentinean Patagonia pollution: PBDEs, OCPs and PCBs in different matrices from the Río Negro basin.

Sci Total Environ 2013 May 22;452-453:275-85. Epub 2013 Mar 22.

Laboratorio de Ecotoxicología y Contaminación Ambiental, FCEyN, Universidad Nacional de Mar del Plata, Mar del Plata, Argentina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.scitotenv.2013.02.055DOI Listing
May 2013
11 Reads
1 Citation
4.100 Impact Factor

Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach.

Epidemiology 2013 May;24(3):454-60

Cancer Registry of Catalonia-Plan for Oncology of the Catalan Government, IDIBELL, Hospital Duran i Reynals, Av. Gran Via de l'Hospitalet, L'Hospitalet de Llobregat, Catalonia, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/EDE.0b013e31828b0866DOI Listing
May 2013
7 Reads
2 Citations
6.200 Impact Factor

Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.

Eur J Hum Genet 2013 May 5;21(5):511-6. Epub 2012 Sep 5.

Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, L'Hospitalet de Llobregat, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2012.204DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641380PMC
May 2013
10 Reads
7 Citations
4.350 Impact Factor

Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study).

Cancer Causes Control 2013 Mar 16;24(3):549-57. Epub 2012 May 16.

Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology, Avda Gran Via 199-203, 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-012-9992-zDOI Listing
March 2013
2 Reads
16 Citations
2.735 Impact Factor

BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations.

Carcinogenesis 2013 Feb 16;34(2):314-8. Epub 2012 Nov 16.

Fundación Pública Galega de Medicina Xenómica-Grupo de Medicina Xenómica-Centro de Investigación Biomédica en Red de Enfermedades Raras-IDIS, Santiago de Compostela 15706, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgs357DOI Listing
February 2013
85 Reads
5 Citations
5.334 Impact Factor

Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.

Inflamm Bowel Dis 2013 Jan;19(1):165-73

Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ibd.22994DOI Listing
January 2013
35 Reads
10 Citations
4.464 Impact Factor

[Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study].

Gac Sanit 2012 Jul-Aug;26(4):301-10. Epub 2012 Apr 21.

Servei d'Epidemiologia i Avaluació, Hospital del Mar, Parc de Salut Mar, Barcelona, España.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gaceta.2012.01.020DOI Listing
November 2012
8 Reads
1 Citation
1.250 Impact Factor

Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.

Clin Chem 2012 Sep 27;58(9):1332-41. Epub 2012 Jun 27.

Translational Research Laboratory, Catalan Institute of Oncology-ICO-IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2012.186577DOI Listing
September 2012
42 Reads
14 Citations
7.911 Impact Factor

False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.

J Med Screen 2012 Jun 31;19(2):77-82. Epub 2012 May 31.

Cancer Prevention and Control Group, IDIBELL, L’Hospitalet de Llobregat, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1258/jms.2012.012013DOI Listing
June 2012
10 Reads
5 Citations
2.722 Impact Factor

Top co-authors

Rebeca Sanz-Pamplona
Rebeca Sanz-Pamplona

Catalan Institute of Oncology

15
Gabriel Capella
Gabriel Capella

L'Hospitalet de Llobregat

15
Manolis Kogevinas
Manolis Kogevinas

Centre for Research in Environmental Epidemiology (CREAL)

15
Marina Pollan
Marina Pollan

National Center for Epidemiology

12
Ramon Salazar
Ramon Salazar

Catalan Institute of Oncology

11
Nuria Aragones
Nuria Aragones

Carlos III Institute of Health

11
Laura Valle
Laura Valle

Catalan Institute of Oncology

10
Jone M Altzibar
Jone M Altzibar

Imperial College London

10